Holders — by stockHoldings — by fund
ENAVATE SCIENCES GP, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001953107
$279.8M
disclosed book value
8
positions
28.1%
largest position share
Positions, as of 2026-09-30
top 8 of 8 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | ZBIOZENAS BIOPHARMA INC | 2.9M | $78.7M | 28.1% |
| 2 | IMNMIMMUNOME INC | 3.6M | $77.7M | 27.8% |
| 3 | BRVEBRAVEHEART BIO INC | 3.7M | $74.2M | 26.5% |
| 4 | SIONSIONNA THERAPEUTICS INC | 2.5M | $13.0M | 4.7% |
| 5 | UPBUPSTREAM BIO INC | 2.5M | $13.0M | 4.6% |
| 6 | BBOTBRIDGEBIO ONCOLOGY THERAPEUT | 2.6M | $10.8M | 3.8% |
| 7 | CMPXCOMPASS THERAPEUTICS INC | 7.8M | $8.1M | 2.9% |
| 8 | CAMPCAMP4 THERAPEUTICS CORP | 1.0M | $4.2M | 1.5% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.